May 19, 2025

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

NRG Oncology Summer Meeting Registration is OPEN

More information can be found on our

Summer Meeting

webpage. 

NRG SUMMER MEETING

NRG Oncology Summer Meeting Registration is Now Open!

Join us in Washington DC for the NRG2025 Summer Meeting. The meeting will be held in-person at the Marriott Marquis, July 24-26, 2025, with select virtual sessions being held July 16-25, 2025. Register soon to avoid the late registration fee!

More information | Agenda | Register

Real ID Reminder - Travel Requirements

As of May 7, 2025, a REAL ID or another acceptable form of identification, like a passport, is required to board domestic flights. Please visit the DHS website for more information on this travel requirement.

NRG Advanced Practice Provider (APP) Symposium

Calling all APPs! We are pleased to announce our NRG Oncology Advanced Practice Providers (APP) Symposium to be held during the NRG2025 Summer Meeting in Washington, DC on Friday, July 25, 2025, 8:15-9:45am ET. The session will also be available virtually. The goals for the session will be to identify the different roles that APPs can serve in NCI-sponsored research and elevate their involvement in clinical research at practice sites. The session chairs are Deb Bruner, Kathleen Castro, Christa Braun-Inglis, and Melyssa Foust. Please refer to the flyer for additional details. Register for the session via the NRG2025 Summer Meeting registration portal.

AMENDMENTS

CANCER PREVETION & CONTROL

NRG-CC008: Amendment 7; version date: April 28, 2025 (posted on CTSU)

FORM UPDATES

GENITOURINARY

NRG-GU012 - See Broadcast Forms for blank CRFs dated May 02, 2025 (posted on CTSU)  including changes to the baseline TARGET LESION form. The primary tumor should be identified and added to the target lesion form as an additional log line. Immunotherapy forms now allows adding additional forms to each cycle. The Solid tumor evaluation STATUS and RESPONSE form has been updated to enhance reporting disease progression per protocol iRecist.

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BIOSPECIMEN BANKS

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

3. BRAIN

NRG-BN011: The central lab, NYU Langone, will be closed on Monday May 26, 2025 for Memorial Day. Please plan tissue shipments accordingly. 

4. BREAST

NRG-BR007/DEBRA: Updated Pathology Instructions, dated May 16, 2025, and accompanying Exact Sciences Ordering Instructions (US version; Canadian versions) posted on CTSU.

NRG-BR008/HERO: New Trifold Patient Brochure has been posted on CTSU under the CIRB Tab. The brochure is also posted on the NRG Oncology website.

NRG-BR008/HERO: Reminder that this trial is open and actively enrolling patients. Helpful materials pertaining to BR008 can be found on the NRG Oncology website under Clinical Trials/NRG-BR008/Documents & Materials or on the CTSU website.

NRG-BR009/OFSET: Updated Pathology Instructions, dated May 16, 2025, and accompanying Exact Sciences Ordering Instructions (US version; Canadian versions) posted on CTSU.

NSABP B-43, NSABP B-47, NSABP B-52: Final call for submission of data and query resolution for study termination. These legacy NSABP studies are approaching study termination. To give sites an opportunity to improve delinquencies, we would like to request sites respond to queries by May 30^th. Please see the memorandum dated May 16, 2025, posted on CTSU for additional information.

4. GYNECOLOGIC

NRG-GY025: Reminder! Enrollment for this study is still open to all NCTN sites.

NRG-GY026: Now accruing patients of all stages and all histologic subtypes of endometrial cancer.

NRG-GY031: Please note, there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

5. HEAD & NECK

NRG-HN008 - Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important. 

NRG-HN010: HER2-Low Expressing Cohort Opened to Accrual Study Memorandum, dated May 15, 2025 (posted on CTSU).

RTOG 1216: An updated Participant Brochure and a Patient Study Web Page is available on the CTSU website (CIRB Approved Documents > Support Documents).

6. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on NRG-BN014, NRG-BR009, NRG-CC003, NRG-CC005, NRG-CC011, NRG-CC013, NRG-CC014, NRG-HN001, NRG-HN002, and NRG-HN014. Space is limited so register now and reserve your seat. The next webinar training is scheduled for June 11, 2025.

4. REGISTER TODAY: The NRG-GU012 (SAMURAI) Webinar

The NRG-GU012 “SAMURAI” Study Principal Investigators will be hosting a webinar to discuss the trial and accept any questions regarding the study from sites. This webinar will be held on Friday, June 13 from 12-1pm ET / 9-10am PT. NRG-GU012 is a Phase II study of stereotactic ablative radiation therapy (SABR) for patients with unresected renal cell carcinoma receiving immunotherapy.

Register here.

6. Regeneron Reception at ASCO featuring NRG-HN014

Regeneron is hosting a special reception at ASCO on Sunday, June 1, 6-8pm CT, to showcase their Skin Cancer Pipeline, featuring the exciting NRG-HN014 clinical trial. Investigators interested in attending are encouraged to RSVP via the invitation posted here.

7. Updated NRG Research Misconduct Policy and Committee Membership Guidelines

NRG Oncology has recently updated the Research Misconduct Policy and the Committee Membership Guidelines. The new version of these documents can be found on the Policies & Bylaws page of our website.

8. REMINDER! GYN Cancer Committee is Requesting Proposals in Advance of the NRG Winter Meeting

Submission Deadline: June 20, 2025

Submit completed proposals to GYNconcepts@nrgoncology.org. See details here.

9. NRG Member Information Form

We are excited to introduce the NRG Member Information Data Collection Initiative that will allow us to create a comprehensive member database, enabling us to better understand and serve our members. Your information will be kept secure and confidential, ensuring that your privacy is always protected. All members are encouraged to complete the form or indicate that they wish to opt out of this data collection initiative. 

Scan the QR code below or click this link to access the form. 

Questions? Read more here

NRG Oncology 2025 ASCO Presentations

The flyer is now available for all NRG Oncology 2025 ASCO presentations on the NRG website. Click here to view.

NRG Oncology is pleased to report the scientific articles that appeared during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

PUBLISHED ARTICLES

Roach M 3rd, Zhang J, Mohamad O, van der Wal D, Simko JP, DeVries S, Huang HC, Joun S, Schaeffer EM, Morgan TM, Keim-Malpass J, Chen E, Yamashita R, Monson JM, Naz F, Wallace J, Bahary JP, Wilke D, Batra S, Biedermann GB, Faria S, Hwang L, Sandler HM, Spratt DE, Pugh SL, Esteva A, Tran PT, Feng FY. Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials. JCO Clin Cancer Inform. 2025 May;9:e2400284. doi: 10.1200/CCI-24-00284. Epub 2025 May 9. PMID: 40344545. Read more

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS:

American Brachytherapy Society (ABS); Jun 18-21, 2025; Nashville, TN

American Society of Clinical Oncology (ASCO); May 30-Jun 3, 2025; Chicago, IL

Canadian Association of Radiation Oncology (CARO); Sep 10-13, 2025; Calgary, AB

ESMO Gynaecological Cancers; Jun 19-21, 2025; Vienna, Austria

International Society for Quality-of-Life Research (ISOQOL); Oct 22-25, 2025; Milwaukee, WI

Radiological Society of North America (RSNA); Nov 30-Dec 4, 2025; Chicago, IL

Society for Clinical Trials (SCT); May 18-21, 2025; Vancouver, BC

Western Association of Gynecologic Oncologists (WAGO); Jun 18-21, 2025; Colorado Springs, CO

UPCOMING ABSTRACT SUBMISSION DEADLINES:

AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; Sep 18-21, 2025; Baltimore, MD; Due to publications committee Jun 10, 2025; Submission deadline Jun 24, 2025, 1:00 pm ET

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; Oct 22-26, 2025; Boston, MA; Due to publications committee Jul 7, 2025; Submission deadline Jul 21, 2025, 1:00 pm ET; LBA and Clinical Trials Sep 10, 2025, 1:00 pm ET

American Society for Radiation Oncology (ASTRO); Sep 28-Oct 1, 2025; San Francisco, CA; LBA Jul 10, 2025, 11:59 pm PT

European Society for Medical Oncology (ESMO); Oct 17-21, 2025; Berlin, Germany; LBA Sep 9, 2025, 21:00 CET (placeholder required)

ESMO Gastrointestinal Cancers; Jul 2-5, 2025; Barcelona, Spain; LBA Jun 5, 2025, 21:00 CET (placeholder required)

International Gynecologic Cancer Society (IGCS); Nov 5-7, 2025; Cape Town, South Africa; LBA Sep 29, 2025 (placeholder required)

San Antonio Breast Cancer Symposium (SABCS); Dec 9-12, 2025; San Antonio, TX; Due to publications committee Jun 25, 2025; Submission deadline Jul 9, 2025, 6:00 pm CT; LBA Sep 30, 2025, 11:59 pm CT

Society for Immunotherapy of Cancer (SITC); Nov 5-9, 2025; National Harbor, MD; Due to publications committee Jun 12, 2025; Submission deadline Jun 26, 2025

Society for Neuro-Oncology (SNO); Nov 19-23, 2025; Honolulu, HI; Due to publications committee May 23, 2025; Submission deadline Jun 6, 2025, 11:59 pm ET; LBA Sep 2, 2025, 5:00 pm ET

Society of Urologic Oncology (SUO); Dec 2-5, 2025; Dallas, TX; Due to publications committee Jul 22, 2025; Submission deadline Aug 5, 2025